Sitemap - 2022 - Geneva Health Files

Reflections on Self-Publishing [2022]: Year Three, Geneva Health Files

Wrap of the Final Quarter

High Drama, But No Outcome at the WTO: TRIPS Extension Decision for COVID-19 Tests & Treatments

Hours to Deadline, Countries Remain Divided at WTO on Extending Temporary Easing of IP rules for COVID-19 Tests & Treatments

Geneva Health Files Receives Grant from Open Society Foundations.

Emerging Fault Lines Suggest Tough Negotiations Ahead, As Countries Reveal Interests: WHO Pandemic Accord

WTO could defer decision on COVID-19 tests & treatments, fueled by American resistance to ease IP rules

"Leverage the advances happening in science, to improve health": Q&A Soumya Swaminathan

EU's Global Health Strategy as Seen Through the Geneva Lens

Safeguarding Article 21 Of The WHO Constitution For Future Global Health Governance [Guest Essay]

What Weak Governance Means for Digital Health: A View from the Field; No Consensus yet on COVID Meds & Tests at the WTO

Equity Rules. The CONCEPTUAL Zero Draft of the Pandemic Accord

Financing for PPR? Stop Global Tax Abuse, Cancel Debt: The Call for Financial Justice

Amendments to the IHR Come to the Fore. Will the Pandemic Accord Lose Traction?

Deutsche Digest: Germany Undecided on COVID Tests & Treatments Talks at the WTO; Berlin's World Health Summit as an Alternate Policy Forum?

The ACT-Accelerator in Transition, a Turning Point?

The Review Committee on the IHR Amendments: Questions on Fairness of Content & Procedure. [Guest Essay]

WHO Pushes for Better Access to COVID-19 Tests & Treatments at the WTO

“Evidence” & “Time” As Obstacles In The Waiver Route For Drugs And Tests For COVID-19 At The WTO

Now Available: A Journalistic Chronicle on the Negotiating History of the TRIPS Waiver Discussions at the WTO

The Fragmentation in Health Emergencies’ Governance: The World Bank’s Fund

Power Asymmetries Re-emerge in the Discussions On COVID-19 Drugs & Tests at the WTO

Walking The Tightrope: Public Health Communication on Monkeypox

How Knowledge Translates into Power in Global Health: The Case of the Metrics

Poor Hygiene in Health Services. Time for Commitments on Infection Prevention and Control?

Listen in: Susan K Sell On the TRIPS Waiver at the WTO

Coming Soon: The TRIPS Waiver Negotiations, A Compilation from Geneva Health Files

Monkeypox: From Neglect & Endemicity to PHEIC, Beyond Legal Characterizations.

What does the global health industry mean by “digital health” and why it matters?

Deconstructing the TRIPS Waiver Discussions: The Susan Sell Interview

No Mandate on Extending WTO TRIPS Agreement Decision to Medicines & Tests: The U.S.

Set into Orbit: WHO Member States Agree to Binding Nature of a New Instrument to Govern Pandemics

Climate Looms Over A New Pandemic Accord, Could Risk Crowding Out Access to Medicines & Equity Issues, Experts Say

TRIPS Waiver 2.0 at the WTO: Proponents back at the table to push for therapeutics and diagnostics

WHO Member States Begin to Define Form and Function of a Pandemic Accord

Financing to Fight Pandemics Takes Root at the World Bank; Geneva Health Files Tops International Newsletters on Substack

Trade Won, Health Did Not. A Sliver of a Waiver at the WTO.

"Power" Trips the Waiver at the WTO, no consensus yet hours before the close of MC12

Have India and South Africa, Lead Sponsors of the TRIPS Waiver Proposal, Reconciled to a Weak Text?

So Close, Yet So Far: TRIPS Waiver at the WTO

Science Diplomacy As a Tool for Pandemic Accord Negotiations

A Physician's Journey into Global Health

Is the delay the defeat of the TRIPS Waiver discussions at the WTO?

Health Emergencies Engulf WHO & its Priorities: A Wrap of WHA 75

Curtain-Raiser: WHA75; Tough negotiations on the WTO's IP response to the pandemic

The World Health Assembly: The What, The Why and The How

China's Spokes WTO Quad Waiver Text, Offers to Sidestep if Conditions Met; India & WHO: An Uneasy Equation

Geneva Health Files Summer Fellows: 2022

WTO DG Serves Up New Proposed Text on the TRIPS Waiver to a Divided House, Tense Negotiations Expected

Member States Pull Back WHO from the Brink of Irrelevance, Reach Consensus to Pay More in Dues.

Pfizer Allegedly Pressured UNICEF to Keep Secret, Pricing for Anti-Viral Treatment Paxlovid. UNICEF Yielded.

The Chronic Crisis in WHO Financing: A Temperature Check on Member States' Commitments [Sustainable Financing Update]

Public Hearings on a Pandemic Agreement Open Floodgates of Interest; WTO DG To Take Compromise Text on TRIPS Waiver to the Wider Membership

Guest Editorial: "A New Pandemic Treaty Must Be Built for Accountability"

Countries Find Chaos in Parallel Tracks on Drawing Up New Rules for Health Emergencies, Many Unprepared

Geneva Health Files: Behind The Scenes

The Compromise Text on the TRIPS Waiver Will Undermine Vaccine Donations

Curb Private Sector Participation In The Treaty-Making Process: Some Member States At WHO

The Lowest Common Denominator: The Quad Text on the TRIPS Waiver

A compromise on the horizon? TRIPS Waiver talks in the 'Quad' at the WTO

The eclipsing of COVID-19; Ukrainian crisis fractures multilateralism in Geneva

Game on at WHO: International Health Regulations Vs The Pandemic Treaty

Efforts to Narrow the TRIPS Waiver Continue: "Eligibility Requirements" Still on The Table

The EU's Vaccine Production Race in Africa; Delaying Tactics Risk Irrelevance of The TRIPS Waiver

The Geneva Health Files Summer Fellowship 2022

The Political Utility of The WHO mRNA Hub - An Analysis

EXCLUSIVE: Efforts to limit the implementation of the TRIPS Waiver, proposals to exclude India & China

Guest Editorial: WHO under DG Tedros - The Last Five Years

The Inevitable Fragmentation of Global Health: The Signs from WHO EB 150

Guest Editorial: The Alcohol Industry and WHO's Global Alcohol Action Plan

A Profound Shift is Underway: A Curtain Raiser Ahead of the WHO 150th Executive Board

Divergences Continue on the Approaches to Reform the Governance of Health Emergencies [WGPR Update]; WTO Members See No Urgency on Convening Meeting for TRIPS Waiver

Pandemic Enters the Third Year, Deepening Challenges; No Consensus Among Member States on Beefing Up WHO Finances